Organized under the flag of the European Immunogenicity Platform (EIP), a central meeting place for European biopharmaceutical companies and scientific experts active in the field of immunogenicity.

Talk and discuss with the experts in immunogenicity!

The meeting format – with plenary lectures and interactive working groups with no more than 40 people – will give everyone the opportunity to meet the experts and discuss novel technologies.

Congress President:
Huub Schellekens, Department of Pharmaceutical Sciences, Utrecht University, Netherlands

Organization Committee:
Sebastian Spindeldreher, Novartis, Switzerland
Arno Kromminga, IPM Biotech, Hamburg, Germany
Christian Ross, Novo Nordisk, Switzerland
Birgit Reipert, Baxter, Austria
Philippe Stas, Algonomics, Gent, Belgium
Wim Jiskoot, Leiden University, Netherlands


The conference program will be available soon.
Presenters at the 2009 symposium included
Keynote speaker: Polly Matzinger (NIAID, NIH)
Martin F. Bachmann (Cytos); Søren Buus (Univ. Copenhagen)
Viswanath Devanarayan (Abbott)
Andreas Greinacher (Univ. Greifswald)
ClausNielsen (Copenhagen University Hospital)
Gopi Shankar (J&J)
Steve Swanson (Amgen)
Gert-Jan Wolbink (Sanquin)
and others.

Registration, fees and deadline::
The conference fee is 595,- Euro. By sending in the registration form, you agree to fulfill payment. A confirmation letter (with invoice) will be sent after registration.
Registration is possible until December 1st 2010, with a maximum of 120 participants.

Hotel accommodation:
Hotel accommodation is not included in the course fee. We have made blocked bookings at 3 nearby hotels.
You still have to make your own reservation at these hotels, which should be requested timely. Availability cannot be guaranteed beyond October 1 2010.

Cancellations:
Cancellations are free of charge until Oct 1st 2010. Cancellations made from Oct 1st - Nov 1st 2010 will be charged 50% of the course fee. After Nov 1st 2010, the full course fee is due upon cancellation

Submit your abstract .